Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaOncologiaSaluteScienza

96 comunicati stampa

Guarda tutti i comunicati
17/09/2026
Igiene alimentare
Sanità
Tecnica
Medicina nucleare
Farmaceutica
Medicina - Varie
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Scienza
Salute
Industria
bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
09/09/2026
Oncologia
Attrezzature medico-sanitarie
Salute
Sanità
Farmaceutica
Biotecnologia
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
03/09/2026
Eventi
Web e Social Network
Oncologia
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Medicina nucleare
Farmaceutica
Biotecnologia
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
01/09/2026
Industria
Igiene alimentare
Sanità
Tecnica
Medicina nucleare
Farmaceutica
Medicina - Varie
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Scienza
Salute
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
20/08/2026
Finanza
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
18/08/2026
Mercato del lavoro
Industria
Attrezzature medico-sanitarie
Biotecnologia
Politica Interna
Salute
Medicina nucleare
Oncologia
Scienza
Difesa / Forze Armate
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
14/08/2026
Finanza
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
13/08/2026
Finanza
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/08/2026
Mercato azionario
Oncologia
Salute
Sanità
Management
Biotecnologia
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
27/07/2026
Industria
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0